CULLINAN THERAPEUTICS INC (CGEM) Forecast, Price Target & Analyst Ratings

NASDAQ:CGEM • US2300311063

Current stock price

13.25 USD
+0.03 (+0.23%)
At close:
13.396 USD
+0.15 (+1.1%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CULLINAN THERAPEUTICS INC (CGEM).

Forecast Snapshot

Consensus Price Target

Price Target
$34.43
+ 159.81% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 7, 2026
Period
Q1 / 2026
EPS Estimate
-$0.84
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
88.42%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$34.43
Upside
+ 159.81%
From current price of $13.25 to mean target of $34.43, Based on 19 analyst forecasts
Low
$24.24
Median
$33.66
High
$55.65

Price Target Revisions

1 Month
4.38%
3 Months
3.85%

Price Target Summary

19 Wall Street analysts provided a forecast for the next 12 months for CGEM. The average price target is 34.42 USD. This implies a price increase of 159.81% is expected in the next year compared to the current price of 13.25.
The average price target has been revised upward by 3.85% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CGEM Current Analyst RatingCGEM Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

CGEM Historical Analyst RatingsCGEM Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
88.42%
CGEM was analyzed by 19 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about CGEM.
In the previous month the buy percentage consensus was at a similar level.
CGEM was analyzed by 19 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-11WedbushMaintains Outperform -> Outperform
2026-02-17CitigroupInitiate Buy
2026-02-02GuggenheimInitiate Buy
2026-01-08HC Wainwright & Co.Maintains Buy -> Buy
2025-12-09WedbushMaintains Outperform -> Outperform
2025-11-24BTIGMaintains Buy -> Buy
2025-11-20HC Wainwright & Co.Maintains Buy -> Buy
2025-09-12HC Wainwright & Co.Reiterate Buy -> Buy
2025-09-10BTIGReiterate Buy -> Buy
2025-08-18Morgan StanleyMaintains Overweight -> Overweight
2025-06-11StifelReiterate Buy
2025-05-12UBSMaintains Buy -> Buy
2025-04-16HC Wainwright & Co.Reiterate Buy -> Buy
2025-02-28HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-29HC Wainwright & Co.Maintains Buy -> Buy
2024-10-24UBSInitiate Buy
2024-10-16HC Wainwright & Co.Reiterate Buy -> Buy
2024-09-18WedbushReiterate Outperform -> Outperform
2024-09-17HC Wainwright & Co.Reiterate Buy -> Buy
2024-09-16HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-09WedbushReiterate Outperform -> Outperform
2024-06-03HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-24HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-16WedbushReiterate Outperform -> Outperform
2024-05-16HC Wainwright & Co.Maintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 7, 2026
Period
Q1 / 2026
EPS Estimate
-$0.84
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
-13.95%
Number of Analysts
15

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
-0.82%
EPS (3 Months)
2.16%

Next Earnings Summary

CGEM is expected to report earnings on 5/7/2026. The consensus EPS estimate for the next earnings is -0.84 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
CGEM revenue by date.CGEM revenue by date.
18.94M141.16M
-100.00%		25.613M26.944M
5.20%		42.816M
58.91%		71.134M
66.14%		286.3M
302.48%		284.84M
-0.51%		171.36M
-39.84%		324.36M
89.29%
EBITDA
YoY % growth
CGEM ebitda by date.CGEM ebitda by date.
-22.2M
-52.58%		-60.28M
-171.53%		-67.9M
-12.64%		147.98M
-91.53%		-195.671M
-46.36%		-198.123M
-3.30%		-235.794M
-19.93%		-172.703M
26.76%		-217.797M
-26.11%		-273.1M
-25.39%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
CGEM ebit by date.CGEM ebit by date.
-22.27M
-52.64%		-60.34M
-170.95%		-67.95M
-12.61%		148.39M
-91.52%		-196.334M
-46.50%		-197.881M
-3.29%		-246.392M
-25.12%		-215.977M
12.34%		-230.076M
-6.53%		-263.829M
-14.67%		-313.152M
-18.70%		-175.307M
44.02%		-184.977M
-5.52%		-262.14M
-41.71%		-99.96M
61.87%
Operating Margin
CGEM operating margin by date.CGEM operating margin by date.
N/AN/A-358.76%105.12%N/AN/AN/A-843.23%-853.90%-616.19%-440.23%-61.23%-64.94%-152.98%-30.82%
EPS
YoY % growth
CGEM eps by date.CGEM eps by date.
N/AN/A-1.50
9.41%		2.38
258.00%		-4.17
-255.70%		-3.12
17.89%		-3.63
-10.56%		-3.01
10.01%		-2.91
3.61%		-2.80
3.72%		-2.92
-4.27%		-0.24
91.78%		-2.61
-989.36%		-1.69
35.16%		-0.64
62.05%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.84
-13.95%		-0.86
20.08%		-0.89
-16.19%		-0.44
43.40%		-0.86
-2.21%		-0.79
7.56%		-0.88
1.38%		-0.50
-15.85%
Revenue
Q2Q % growth		28.459MN/AN/AN/AN/A
EBITDA
Q2Q % growth		-58.217M
-6.00%		-60.209M
20.41%		-62.215M
-12.38%		13.896M
125.29%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-57.66M
-4.84%		-59.566M
21.41%		-61.562M
-10.73%		-30.674M
44.49%		-62.22M
-7.91%		-63.444M
-6.51%		-64.77M
-5.21%		36.006M
217.38%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CGEM Yearly Revenue VS EstimatesCGEM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M
CGEM Yearly EPS VS EstimatesCGEM Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 -4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
5.22%
EPS Next 5 Year
14.04%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-3.25%
EBIT Next 5 Year
-8.39%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

CULLINAN THERAPEUTICS INC / CGEM Forecast FAQ

Can you provide the average price target for CULLINAN THERAPEUTICS INC stock?

19 analysts have analysed CGEM and the average price target is 34.42 USD. This implies a price increase of 159.81% is expected in the next year compared to the current price of 13.25.

What is the next earnings date for CGEM stock?

CULLINAN THERAPEUTICS INC (CGEM) will report earnings on 2026-05-07.

What are the consensus estimates for CGEM stock next earnings?

The consensus EPS estimate for the next earnings of CULLINAN THERAPEUTICS INC (CGEM) is -0.84 USD and the consensus revenue estimate is 0 USD.